Historical record - last NADAC effective date: 6/22/2022
Product Information
MEMANTINE HCL 5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0929 per EA under NDC 62332007591. Its NADAC has been published 288 times since Dec 21, 2016.
FDA first approved this application on Oct 13, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332007591
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
6/22/2022
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200891FDA Approved
10/13/2015
TE Code
AB
On Market Since
10/13/2015
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL 5 MG TABLET has been published 288 times since Dec 21, 2016, and over the history we have for it it has declined 59.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0929 per EA |
|---|---|
| All-time high | $0.2292 (Jan 11, 2017) |
| All-time low | $0.0817 (Dec 22, 2021) |
| Median price | $0.1216 |
| Average price | $0.1290 |
| Largest weekly change | -16.3% (Feb 17, 2021) |
| Weeks tracked | 288 |
| Tracking since | Dec 21, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-1.9%
All
-59.4%
Last surveyed Jun 22, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
memantine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
N-methyl-D-aspartate Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL 5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0929 per EA (NDC 62332007591), effective Jun 22, 2022.
How has the price of MEMANTINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL 5 MG TABLET has declined 59.4%. It has been tracked across 288 weekly CMS publications since Dec 21, 2016.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL 5 MG TABLET?
Since Dec 21, 2016, the NADAC for MEMANTINE HCL 5 MG TABLET has ranged from a low of $0.0817 (Dec 22, 2021) to a high of $0.2292 (Jan 11, 2017), with a median of $0.1216 per EA.
Are there cheaper alternatives to MEMANTINE HCL 5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEMANTINE HCL 5 MG TABLET, is $0.0793 per EA — about 15% below MEMANTINE HCL 5 MG TABLET.
Who manufactures MEMANTINE HCL 5 MG TABLET?
MEMANTINE HCL 5 MG TABLET (NDC 62332007591) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.